Family genetic screening methods for heart rhythm risk
Part of Genetic & congenital, Heart & circulation, Hormones & metabolism clinical trials.
This study compares two ways to find relatives who may carry a specific inherited genetic change. It may help your family learn faster who should get follow-up testing and care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old
- You (the person being tested) carry either the KCNQ1 Thr224Met change or the APOB R3527Q change
- You have a first-degree relative (parent, child, or sibling) of that person
- Your first-degree relative is also part of the family being screened
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is about helping families with familial hypercholesterolemia (a genetic condition that causes very high cholesterol) get screened. It tests a way to reach close relatives so they can learn their risk and consider next steps.
This study is building a database to better understand how different changes in the KCNH2 gene affect health. It may help doctors make more accurate diagnoses and predictions for people with this gene variant.
This study looks for family members of people with familial hypercholesterolemia (FH), a genetic condition that causes very high cholesterol. The goal is to help find and screen relatives who may also have FH, so they can get earlier care.
This study looks at how children with certain genetic heart rhythm problems, like long QT syndrome, respond to exercise. It may help doctors understand how to better manage these conditions.
This trial aims to identify kids and teens who may have inherited high cholesterol (especially LDL) and may be at higher risk for early heart artery disease. It may help families learn about their risk and ensure the right follow-up and treatment plan.
This study uses your blood or genetic information to make “iPS cells,” lab-grown cells that can help researchers study inherited heart rhythm problems like LQTS, Brugada syndrome, CPVT, or early repolarization syndrome. It may help improve understanding of why these rhythms happen and guide future treatments.
Hear when a new Long QT Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.